GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 281 filers reported holding GW PHARMACEUTICALS PLC in Q4 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $2,761,000 | -57.9% | 24,000 | -36.8% | 1.26% | -43.7% |
| Q2 2019 | $6,551,000 | -61.3% | 38,000 | -62.2% | 2.23% | -73.9% |
| Q1 2019 | $16,941,000 | +2800.9% | 100,500 | +1575.0% | 8.54% | +750.8% |
| Q4 2018 | $584,000 | -48.8% | 6,000 | -9.1% | 1.00% | +63.3% |
| Q3 2018 | $1,140,000 | +308.6% | 6,600 | +230.0% | 0.62% | +404.1% |
| Q2 2018 | $279,000 | -83.7% | 2,000 | -84.6% | 0.12% | -84.0% |
| Q4 2017 | $1,716,000 | – | 13,000 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
| Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
| Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
| Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
| CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
| FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
| Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
| PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |